Refine
Year of publication
Document Type
- Article (42)
- Preprint (4)
- Part of a Book (1)
Has Fulltext
- yes (47)
Is part of the Bibliography
- no (47)
Keywords
- Parkinson’s disease (6)
- Parkinson's disease (3)
- Ataxia telangiectasia (2)
- Mitochondrial dysfunction (2)
- Neurodegeneration (2)
- PINK1 (2)
- alpha-synuclein (2)
- amyotrophic lateral sclerosis (ALS) (2)
- leukodystrophy (2)
- pain (2)
- AAA+ disaggregase (1)
- ATXN2 (1)
- Advanced glycation endproducts (1)
- Aggregation (1)
- Albumin ratio (1)
- Alleles (1)
- Alpha-synuclein (1)
- Alpha-synuclein deficiency (1)
- Amyotrophic lateral sclerosis (1)
- Antiviral response (1)
- Ataxia (1)
- Ataxia score (1)
- Atxn2 (1)
- Autoimmune vasculopathy (1)
- Autophagy (1)
- Biomarker (1)
- Biomarkers (1)
- Bipolar disorder (1)
- CPT1A (1)
- Calcium (1)
- Cancer (1)
- Cell cycle (1)
- Cellular stress (1)
- Cerebellar ataxia (1)
- Cerebellum (1)
- Cerebrospinal fluid (1)
- ClpB (1)
- Complexin 1 (1)
- Complexin-1 (1)
- Consortia (1)
- Cyp46a1 (1)
- Cytokines (1)
- Depression (1)
- Disease progression (1)
- ERAL1 (1)
- Etiology (1)
- Foxp1 (1)
- Frontotemporal dementia (1)
- Genome-wide association studies (1)
- Global protein synthesis rates (1)
- Glucose metabolism (1)
- Glyoxalase I (1)
- HARS2 (1)
- Hmox1 (1)
- Homeostasis (1)
- Innate immunity (1)
- Ireb2 (1)
- Itpr1 (1)
- K-homology RNA-binding domain (1)
- LAMP3 (1)
- LARS2 (1)
- Leukodystrophy (1)
- Lipid trafficking (1)
- Lysosome (1)
- MMP14 (1)
- MTRNR1 (1)
- Midbrain/brainstem expression changes (1)
- Mitochondria (1)
- Mitochondrial amino acid tRNA synthetases (1)
- Mitochondrien (1)
- Molecular genetics (1)
- Motor neuron disease (1)
- Neurofilament light chain (1)
- Neuroinflammation (1)
- NfL (1)
- Oxidative stress (1)
- Oxidativer Stress (1)
- PARK2 (1)
- PARK4 (1)
- PARK6 (1)
- PARK7 (1)
- POLG (1)
- PRLTS3 (1)
- PTEN inducible kinase 1 (1)
- PYGL (1)
- Parkin (1)
- Parkinson (1)
- Parkinson disease (1)
- Perrault syndrome (1)
- Pgrmc1 (1)
- Presynaptic vesicles (1)
- Proteasome (1)
- RNA chaperone (1)
- RNA processing (1)
- RNA processing machinery (1)
- Rapid eye movement sleep behavior disorder (1)
- Release of mtDNA and mtRNA (1)
- Ribosomal S6 phosphorylation (1)
- Ribosomal translation (1)
- Rora (1)
- SCA2 (1)
- SCA34 (1)
- SCA38 (1)
- Schizophrenia (1)
- Signaling (1)
- Skin fibroblast (1)
- Slc11a2 (1)
- Slc25a37 (1)
- Spinocerebellar ataxia (1)
- Spinocerebellar ataxia type 2 (1)
- Stroke genetics (1)
- TIA-1 (1)
- TWINKLE (1)
- TWNK (1)
- Tfrc (1)
- Transcriptome (1)
- Transcriptome microarray (1)
- Ubiquitin kinase PINK1 (1)
- Ubiquitin ligase (1)
- Zellulärer Transport (1)
- acid sphingomyelinase (ASMase; Smpd1) (1)
- actography (1)
- amyotrophic lateral sclerosis (1)
- ataxia (1)
- autophagy (1)
- azoospermia (1)
- brain phosphorylome (1)
- cGAS-STING (1)
- ceramide synthase (CERS2/CERS1) (1)
- circadian rhythms (1)
- endocannabinoids (1)
- endogenous clock (1)
- fatty acid elongase (Elovl1/4/5) (1)
- fragile-X-associated tremor-ataxia syndrome (1)
- fronto-temporal lobar dementia (1)
- fronto-temporal-lobar-dementia (1)
- frontotemporal dementia (1)
- glucosylceramides (1)
- iPS (1)
- innate immunity (1)
- inositol signaling (1)
- iron overload versus deprivation (1)
- lipidomic analysis (1)
- long-term potentiation (1)
- microtubular cytoskeleton (1)
- mitochondrial respiration (1)
- motor neuron disease (1)
- mtLSU quality control (1)
- neurexin (1)
- neuroblastoma regression (1)
- neurodegeneration (1)
- neutral ceramidase (Asah2) (1)
- neutral sphingomyelinase (Smpd3) (1)
- nucleotide metabolism (1)
- nutrient endocytosis (1)
- obesity (1)
- olivo-ponto-cerebellar atrophy (OPCA) (1)
- phase separation (1)
- poly(A)-tail (1)
- polyQ (1)
- primary ovarian insufficiency (1)
- prion-like (1)
- protein aggregation (1)
- quantitative sensory testing (1)
- rRNA chaperone ERAL1 (1)
- sensorineural hearing loss (1)
- sensory loss (1)
- sensory neuropathy (1)
- serine palmitoyltransferase 2 (Sptlc2) (1)
- short linear motif (1)
- spatial learning (1)
- spinocerebellar ataxia (1)
- stress granules (1)
- synaptic plasticity (1)
- synaptic signaling (1)
- synuclein (1)
- tauopathies (1)
- tauopathy (1)
- tumor suppressor (1)
- tyrosine kinase receptor signaling (1)
- vesicular glutamate transporter 2 (1)
- α-synuclein (1)
Institute
Mitochondrial matrix peptidase CLPP is crucial during cell stress. Its loss causes Perrault syndrome type 3 (PRLTS3) with infertility, neurodegeneration and growth deficit. Its target proteins are disaggregated by CLPX, which also regulates heme biosynthesis via unfolding ALAS enzyme, providing access of pyridoxal-5’-phosphate (PLP). Despite efforts in diverse organisms with multiple techniques, CLPXP substrates remain controversial. Here, avoiding recombinant overexpression, we employed complexomics in mitochondria from three mouse tissues to identify endogenous targets. CLPP absence caused accumulation and dispersion of CLPX-VWA8 as AAA+ unfoldases, and of PLPBP. Similar changes and CLPX-VWA8 comigration were evident for mitoribosomal central protuberance clusters, translation factors like GFM1-HARS2, RNA granule components LRPPRC-SLIRP, and enzymes OAT-ALDH18A1. Mitochondrially translated proteins in testis showed reductions to <30% for MTCO1-3, misassembly of complex-IV supercomplex, and accumulated metal-binding assembly factors COX15-SFXN4. Indeed, heavy metal levels were increased for iron, molybdenum, cobalt and manganese. RT-qPCR showed compensatory downregulation only for Clpx mRNA, most accumulated proteins appeared transcriptionally upregulated. Immunoblots validated VWA8, MRPL38, MRPL18, GFM1 and OAT accumulation. Coimmunoprecipitation confirmed CLPX binding to MRPL38, GFM1 and OAT, so excess CLPX and PLP may affect their activity. Our data elucidate mechanistically the mitochondrial translation fidelity deficits, which underlie progressive hearing impairment in PRLTS3.
The mitochondrial matrix peptidase CLPP is crucial during cell stress. Its loss causes Perrault syndrome type 3 (PRLTS3) with infertility, neurodegeneration, and a growth deficit. Its target proteins are disaggregated by CLPX, which also regulates heme biosynthesis via unfolding ALAS enzymes, providing access for pyridoxal-5′-phosphate (PLP). Despite efforts in diverse organisms with multiple techniques, CLPXP substrates remain controversial. Here, avoiding recombinant overexpression, we employed complexomics in mitochondria from three mouse tissues to identify endogenous targets. A CLPP absence caused the accumulation and dispersion of CLPX-VWA8 as AAA+ unfoldases, and of PLPBP. Similar changes and CLPX-VWA8 co-migration were evident for mitoribosomal central protuberance clusters, translation factors like GFM1-HARS2, the RNA granule components LRPPRC-SLIRP, and enzymes OAT-ALDH18A1. Mitochondrially translated proteins in testes showed reductions to <30% for MTCO1-3, the mis-assembly of the complex IV supercomplex, and accumulated metal-binding assembly factors COX15-SFXN4. Indeed, heavy metal levels were increased for iron, molybdenum, cobalt, and manganese. RT-qPCR showed compensatory downregulation only for Clpx mRNA; most accumulated proteins appeared transcriptionally upregulated. Immunoblots validated VWA8, MRPL38, MRPL18, GFM1, and OAT accumulation. Co-immunoprecipitation confirmed CLPX binding to MRPL38, GFM1, and OAT, so excess CLPX and PLP may affect their activity. Our data mechanistically elucidate the mitochondrial translation fidelity deficits which underlie progressive hearing impairment in PRLTS3.
Biallelic pathogenic variants in CLPP, encoding mitochondrial matrix peptidase ClpP, cause a rare autosomal recessive condition, Perrault syndrome type 3 (PRLTS3). It is characterized by primary ovarian insufficiency and early sensorineural hearing loss, often associated with progressive neurological deficits. Mouse models showed that accumulations of (i) its main protein interactor, the substrate-selecting AAA+ ATPase ClpX, (ii) mitoribosomes, and (iii) mtDNA nucleoids are the main cellular consequences of ClpP absence. However, the sequence of these events and their validity in human remain unclear. Here, we studied global proteome profiles to define ClpP substrates among mitochondrial ClpX interactors, which accumulated consistently in ClpP-null mouse embryonal fibroblasts and brains. Validation work included novel ClpP-mutant patient fibroblast proteomics. ClpX co-accumulated in mitochondria with the nucleoid component POLDIP2, the mitochondrial poly(A) mRNA granule element LRPPRC, and tRNA processing factor GFM1 (in mouse, also GRSF1). Only in mouse did accumulated ClpX, GFM1, and GRSF1 appear in nuclear fractions. Mitoribosomal accumulation was minor. Consistent accumulations in murine and human fibroblasts also affected multimerizing factors not known as ClpX interactors, namely, OAT, ASS1, ACADVL, STOM, PRDX3, PC, MUT, ALDH2, PMPCB, UQCRC2, and ACADSB, but the impact on downstream metabolites was marginal. Our data demonstrate the primary impact of ClpXP on the assembly of proteins with nucleic acids and show nucleoid enlargement in human as a key consequence.
Ataxia telangiectasia (A-T) is a progressive and life-limiting disease associated with cerebellar ataxia due to progressive cerebellar degeneration. In addition to ataxia, which is described in detail, the presence of chorea, dystonia, oculomotor apraxia, athetosis, parkinsonism, and myoclonia are typical manifestations of the disease. The study aimed to evaluate the specificity and sensitivity of neurofilament light chain (NfL) as a biomarker of neurodegeneration in relation to SARA score. In this prospective trial, one visit of 42 A-T patients aged 1.3–25.6 years (mean 11.6 ± 7.3 years) was performed, in which NfL was determined from serum by ELISA. Additionally, a neurological examination of the patients was performed. Blood was collected from 19 healthy volunteers ≥ 12 years of age. We found significantly increased levels of NfL in patients with A-T compared to healthy controls (21.5 ± 3.6 pg/mL vs. 9.3 ± 0.49 pg/mL, p ≤ 0.01). There was a significant correlation of NfL with age, AFP, and SARA. NfL is a new potential progression biomarker in blood for neurodegeneration in A-T which increases with age.
Human RNF213, which encodes the protein mysterin, is a known susceptibility gene for moyamoya disease (MMD), a cerebrovascular condition with occlusive lesions and compensatory angiogenesis. Mysterin mutations, together with exposure to environmental trigger factors, lead to an elevated stroke risk since childhood. Mysterin is induced during cell stress, to function as cytosolic AAA+ ATPase and ubiquitylation enzyme. Little knowledge exists, in which context mysterin is needed. Here, we found that genetic ablation of several mitochondrial matrix factors, such as the peptidase ClpP, the transcription factor Tfam, as well as the peptidase and AAA+ ATPase Lonp1, potently induces Rnf213 transcript expression in various organs, in parallel with other components of the innate immune system. Mostly in mouse fibroblasts and human endothelial cells, the Rnf213 levels showed prominent upregulation upon Poly(I:C)-triggered TLR3-mediated responses to dsRNA toxicity, as well as upon interferon gamma treatment. Only partial suppression of Rnf213 induction was achieved by C16 as an antagonist of PKR (dsRNA-dependent protein kinase). Since dysfunctional mitochondria were recently reported to release immune-stimulatory dsRNA into the cytosol, our results suggest that mysterin becomes relevant when mitochondrial dysfunction or infections have triggered RNA-dependent inflammation. Thus, MMD has similarities with vasculopathies that involve altered nucleotide processing, such as Aicardi-Goutières syndrome or systemic lupus erythematosus. Furthermore, in MMD, the low penetrance of RNF213 mutations might be modified by dysfunctions in mitochondria or the TLR3 pathway.
Biomolecular condensation underlies the biogenesis of an expanding array of membraneless assemblies, including stress granules (SGs) which form under a variety of cellular stresses. Advances have been made in understanding the molecular grammar that dictates the behavior of a few key scaffold proteins that make up these phases but how the partitioning of hundreds of other SG proteins is regulated remains largely unresolved. While investigating the rules that govern the condensation of ataxin-2, a SG protein implicated in neurodegenerative disease, we unexpectedly identified a short 14aa sequence that acts as an ataxin-2 condensation switch and is conserved across the eukaryote lineage. We identify poly(A)-binding proteins as unconventional RNA-dependent chaperones that control this regulatory switch. Our results uncover a hierarchy of cis and trans interactions that fine-tune ataxin-2 condensation and reveal a new molecular function for ancient poly(A)-binding proteins as emulsifiers of biomolecular condensate proteins. These findings may inspire novel approaches to therapeutically target aberrant phases in disease.
Autosomal recessive Ataxia Telangiectasia (A-T) is characterized by radiosensitivity, immunodeficiency and cerebellar neurodegeneration. A-T is caused by inactivating mutations in the Ataxia-Telangiectasia-Mutated (ATM) gene, a serine-threonine protein kinase involved in DNA-damage response and excitatory neurotransmission. The selective vulnerability of cerebellar Purkinje neurons (PN) to A-T is not well understood.
Multiplex families with a high prevalence of a psychiatric disorder are often examined to identify rare genetic variants with large effect sizes. In the present study, we analysed whether the risk for bipolar disorder (BD) in BD multiplex families is influenced by common genetic variants. Furthermore, we investigated whether this risk is conferred mainly by BD-specific risk variants or by variants also associated with the susceptibility to schizophrenia or major depression. In total, 395 individuals from 33 Andalusian BD multiplex families as well as 438 subjects from an independent, sporadic BD case-control cohort were analysed. Polygenic risk scores (PRS) for BD, schizophrenia, and major depression were calculated and compared between the cohorts. Both the familial BD cases and unaffected family members had significantly higher PRS for all three psychiatric disorders than the independent controls, suggesting a high baseline risk for several psychiatric disorders in the families. Moreover, familial BD cases showed significantly higher BD PRS than unaffected family members and sporadic BD cases. A plausible hypothesis is that, in multiplex families with a general increase in risk for psychiatric disease, BD development is attributable to a high burden of common variants that confer a specific risk for BD. The present analyses, therefore, demonstrated that common genetic risk variants for psychiatric disorders are likely to contribute to the high incidence of affective psychiatric disorders in the multiplex families. The PRS explained only part of the observed phenotypic variance and rare variants might have also contributed to disease development.
Ataxia telangiectasia (A-T) is a devastating multi-system disorder characterized by progressive cerebellar ataxia and immunodeficiency. The neurological decline may be caused by multiple factors of which ongoing inflammation and oxidative stress may play a dominant role. The objective of the present investigation was to determine cerebrospinal fluid (CSF) proteins and possible low-grade inflammation and its relation to age and neurological deterioration. In the present study, we investigated 15 patients with A-T from 2 to 16 years. Our investigation included blood and CSF tests, clinical neurological examination, A-T score, and MRI findings. The albumin ratio (AR) was analyzed to determine the blood–brain-barrier function. In addition, inflammatory cytokines (IL-1α, IL-6, IL-8, IL-12 p40, IL-17A, IFN-γ, TNF-α) were measured by the multiplex cytometric bead array. We compared the results with those from an age-matched control group. Three of the A-T patients were analyzed separately (one after resection of a cerebral meningioma, one after radiation and chemotherapy due to leukemia, one after stem cell transplantation). Patient had significantly more moderate and severe side effects due to CSF puncture (vomiting, headache, need for anti-emetic drugs) compared with healthy controls. Total protein, albumin, and the AR increased with age indicating a disturbed blood barrier function in older children. There were no differences for cytokines in serum and CSF with the exception of IL-2, which was significantly higher in controls in serum. The AR is significantly altered in A-T patients, but low-grade inflammation is not detectable in serum and CSF.